GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

11053	Companies
242355	Keywords
170652	Articles
130447	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 02/14/2025 at 22:10, 1 year 7 months ago

GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders
GENFIT announces amendment of final terms of dual proposal to 2025 OCEANEs holders, seeking consent for repurchase at EUR 32.75 per bond or a consent fee of EUR 0.90 per bond still outstanding

Repurchase Amendment GENFIT Consent Fee 2025 OCEANEs
BRIEF

published on 02/10/2025 at 07:35, 1 year 7 months ago

GENFIT Proposes Terms for 2025 OCEANEs Bondholders

Royalty Financing GENFIT Bond Repurchase Financial Terms 2025 OCEANEs
BRIEF

published on 02/10/2025 at 07:35, 1 year 7 months ago

GENFIT propose des modalités aux porteurs d'OCEANEs 2025

Rachat D'obligations GENFIT Conditions Financières OCEANE 2025 Financement Par Redevances
PRESS RELEASE

published on 02/10/2025 at 07:30, 1 year 7 months ago

GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
GENFIT announces final terms for dual proposal to the 2025 OCEANEs holders, offering to repurchase bonds at EUR 32.00 or pay a consent fee of EUR 0.60 per bond. Proposals subject to bondholders' approval and closing of royalty financing

Repurchase Royalty Financing GENFIT Consent Fee 2025 OCEANEs
PRESS RELEASE

published on 02/10/2025 at 07:30, 1 year 7 months ago

GENFIT annonce les termes définitifs de sa double proposition aux porteurs d’OCEANEs 2025
GENFIT annonce les termes de sa double proposition aux porteurs d'OCEANEs 2025, incluant le rachat des obligations ou un paiement financier, liés au royalty financing avec HCRx. Modalités d'approbation et mise en œuvre

Rachat Royalty Financing GENFIT OCEANEs 2025 Contrepartie Financière
BRIEF

published on 02/06/2025 at 22:15, 1 year 7 months ago

GENFIT dévoile ses futurs essais cliniques et attentes pour 2025

Biopharmaceutique Essais Cliniques 2025 GENFIT ACLF
BRIEF

published on 02/06/2025 at 22:15, 1 year 7 months ago

GENFIT unveils its future clinical trials and expectations for 2025

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF
PRESS RELEASE

published on 02/06/2025 at 22:10, 1 year 7 months ago

GENFIT présente le design de ses prochains essais cliniques et rappelle les grandes étapes de développement et données cliniques attendues en 2025
GENFIT présente le design de ses prochains essais cliniques pour son portefeuille ACLF et rappelle les données cliniques attendues en 2025. Le Directeur Général annonce quatre séries de données cliniques attendues d'ici fin 2025

Développement Essais Cliniques GENFIT ACLF Données Cliniques
PRESS RELEASE

published on 02/06/2025 at 22:10, 1 year 7 months ago

GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
GENFIT outlines anticipated new clinical trial initiations, development milestones, and data readouts in 2025, focusing on Acute on-Chronic Liver Failure (ACLF) pipeline

Clinical Trials Biopharmaceutical 2025 GENFIT ACLF Pipeline
BRIEF

published on 01/30/2025 at 08:45, 1 year 7 months ago

GENFIT Announces €185 Million Royalty Financing Agreement

Biopharmaceutical Royalty Financing GENFIT Debt Resolution ACLF Development

Accesswire

Published on 09/22/2026 at 17:00, 2 hours 37 minutes ago

Leggett Dynamics Expands Asia Pacific Headquarters
Published on 09/22/2026 at 16:30, 3 hours 7 minutes ago

Formation Metals Intersects 0.98 g/t Au over 95.6 Metres Starting 7 Metres Below Surface, Including 3.14 g/t Au over the First 10 Metres, Extending the A-Zone Up to 50 Metres North at N2
Published on 09/22/2026 at 15:25, 4 hours 12 minutes ago

Aztec Minerals Announces Closing of Upsized C$6.4 Million Bought Deal Private Placement Including Concurrent Exercise of Underwriter's Option
Published on 09/22/2026 at 15:20, 4 hours 17 minutes ago

MicroVision Introduces Advanced Photonics Technology for Next-Generation AI Data Center Scale-Up Architecture
Published on 09/22/2026 at 15:05, 4 hours 32 minutes ago

Jaguar Health Receives Fee Waivers from FDA

View all ACCESSWIRE

EQS Group

Published on 09/22/2026 at 19:00, 37 minutes ago

LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:45, 51 minutes ago

MGI Digital Technology: Modification des ressources allouées au contrat de liquidité.
Published on 09/22/2026 at 18:30, 1 hour 7 minutes ago

Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 18:30, 1 hour 7 minutes ago

Voyageurs du Monde: Communiqué sur le dépôt de projet de note en réponse (suite au dépôt de projet de note en réponse de Voyageurs du Monde à l'Autorité des Marchés Financiers)
Published on 09/22/2026 at 18:30, 1 hour 7 minutes ago

IEVA GROUP: Visioconférence actionnaires et investisseurs Jeudi 15 octobre 2026 - 18h00 (CEST)

Les Echos

Published on 09/22/2026 at 18:10, 1 hour 27 minutes ago

Financial statements - 30 june 2026
Published on 09/22/2026 at 18:00, 1 hour 37 minutes ago

Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 1 hour 37 minutes ago

Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 1 hour 52 minutes ago

Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/22/2026 at 17:45, 1 hour 52 minutes ago

Imerys-09-2026-communique-capital-droits-de-vote-au-31-août-2026

View all LES ECHOS COMFI WIRE